5 results
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
20 Oct 23
Current report (foreign)
2:56pm
and through its Audit and Risk Committee.
- A3 -
The Board has a stewardship responsibility to supervise the management of and oversee the conduct
6-K
EX-99.2
IPA
ImmunoPrecise Antibodies Ltd
17 Nov 22
Current report (foreign)
9:36am
of the Company's affairs directly and through its audit committee.
The Board has a stewardship responsibility to supervise the management of and oversee
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
12 Nov 21
Current report (foreign)
8:58am
of the Company’s affairs directly and through its audit committee.
The Board has a stewardship responsibility to supervise the management of and oversee the conduct
F-10
EX-4.6
IPA
ImmunoPrecise Antibodies Ltd
9 Nov 20
Registration of securities (Canada)
8:18am
52-110, except for Jennifer Bath, who is the President and Chief Executive Officer of the Company.
The Board has a stewardship responsibility
40FR12B/A
EX-99.108
IPA
ImmunoPrecise Antibodies Ltd
4 Nov 20
Initial registration of securities (Canada) (amended)
4:05pm
of NI 52-110, except for Jennifer Bath, who is the President and Chief Executive Officer of the Company.
The Board has a stewardship responsibility
- Prev
- 1
- Next